理论分析揭示了RAF在悖论激活中的自抑制作用
Gaurav Mendiratta1, Edward Stites2,3
1Integrative Biology Laboratory, Salk Institute for Biological Studies, La Jolla, United States.
eLife
|October 12, 2023
概括
矛盾的是,RAF激酶抑制剂可以激活RAF信号. 数学建模揭示了形状自抑制调制是推动RAF信号通路中的这种悖论激活 (PA) 的关键机制.
科学领域:
- 生物化学 生化学
- 分子生物学分子生物学
- 计算生物学 计算生物学
背景情况:
- 在癌症治疗中使用RAF激酶抑制剂.
- 矛盾激活 (PA) 是 RAF 抑制剂在特定条件下引起的 RAF 激酶信号的增加.
- 人们还没有完全理解PA的确切机制.
研究的目的:
- 调查 RAF 信号中的悖论激活 (PA) 机制.
- 开发一个数学和计算模型来解释PA.
- 确定有助于PA的关键分子性质.
主要方法:
- 使用数学和计算建模.
- 来自分析表达式来描述PA.
- 分析了实验RAF抑制剂剂量反应数据.
主要成果:
- 通过RAF抑制剂的符合性自身抑制调节可以充分引起PA.
- 一个包含调制形态自抑制,二次亲和力和负合作力的模型最能解释实验PA数据.
- 已确立的构造性自身抑制作为RAF抑制剂驱动的PA的主要机制.
结论:
- 合规自抑制是一种强大的悖论激活机制.
- 该研究提供了基于平衡动态的PA的机械学理解.
- 结果提供了对RAF信号和抑制剂药物设计的见解.
关键词:
生物化学 生物化学化学生物学 化学生物学这是一种计算式计算.计算生物学是计算生物学.分化二元化是指二元化的过程.人类 人类 人类 人类 人类 人类 人类蛋白质激酶酶是一种蛋白质激酶.系统生物学 系统生物学系统建模系统建模模型系统药理学 药理学更多相关视频
相关概念视频
MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
The Two-State Receptor Model
2.0K
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with...
The binding affinity of a drug determines its interaction with...
2.0K
Allosteric Regulation
58.1K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
58.1K
Cooperative Allosteric Transitions
7.9K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.9K
Allosteric Proteins-ATCase
5.8K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.8K
Small GTPases - Ras and Rho
4.0K
Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity:
Three regulatory proteins control their activity:
4.0K


